A Randomized, Double‐Blind, Placebo‐Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss

OBJECTIVE: This study aims to assess the efficacy and safety of Gelesis100, a novel, nonsystemic, superabsorbent hydrogel to treat overweight or obesity. METHODS: The Gelesis Loss Of Weight (GLOW) study was a 24‐week, multicenter, randomized, double‐blind, placebo‐controlled study in patients with B...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenway, Frank L., Aronne, Louis J., Raben, Anne, Astrup, Arne, Apovian, Caroline M., Hill, James O., Kaplan, Lee M., Fujioka, Ken, Matejkova, Erika, Svacina, Stepan, Luzi, Livio, Gnessi, Lucio, Navas‐Carretero, Santiago, Alfredo Martinez, J., Still, Christopher D., Sannino, Alessandro, Saponaro, Cosimo, Demitri, Christian, Urban, Lorien E., Leider, Harry, Chiquette, Elaine, Ron, Eyal S., Zohar, Yishai, Heshmati, Hassan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587502/
https://www.ncbi.nlm.nih.gov/pubmed/30421844
http://dx.doi.org/10.1002/oby.22347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587502/
https://www.ncbi.nlm.nih.gov/pubmed/30421844
http://dx.doi.org/10.1002/oby.22347

Ejemplares similares